In accordance, preliminary evaluation of NF-κB activation by assessment of the phosphorylation of IkBα and of RelA in our transduced T-ALL cell lines did not reveal any obvious differences modulated by miR-146b (data not shown). The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.